Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,018.00
+18.00 (1.80%)
Dec 17, 2025, 5:03 PM IDT
Oramed Pharmaceuticals Revenue
Revenue (ttm)
$6.62M
Revenue Growth
n/a
P/S Ratio
59.78
Revenue / Employee
$1.66M
Employees
4
Market Cap
395.87M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.34M | -1.36M | -50.43% |
| Dec 31, 2022 | 2.70M | - | - |
| Aug 31, 2021 | 2.70M | -7.00K | -0.26% |
| Aug 31, 2020 | 2.71M | 7.00K | 0.26% |
| Aug 31, 2019 | 2.70M | 254.00K | 10.37% |
| Aug 31, 2018 | 2.45M | -7.00K | -0.29% |
| Aug 31, 2017 | 2.46M | 1.82M | 283.15% |
| Aug 31, 2016 | 641.00K | - | - |
| Aug 31, 2015 | - | - | - |
| Aug 31, 2014 | - | - | - |
| Aug 31, 2013 | - | - | - |
| Aug 31, 2012 | - | - | - |
| Aug 31, 2011 | - | - | - |
| Aug 31, 2010 | - | - | - |
| Aug 31, 2009 | - | - | - |
| Aug 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Novolog (Pharm-Up 1966) | 1.97B |
| Ilex Medical | 917.10M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 162.56M |
Oramed Pharmaceuticals News
- 4 weeks ago - Oramed (ORMP) Implements Stockholder Rights Agreement - GuruFocus
- 4 weeks ago - Oramed Pharmaceuticals GAAP EPS of $1.26 - Seeking Alpha
- 4 weeks ago - Oramed Reports Fiscal Third Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS - PRNewsWire
- 7 weeks ago - Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives - PRNewsWire
- 2 months ago - Oramed Pharmaceuticals (ORMP) Receives $13 Million from Scilex for Warrants - GuruFocus
- 8 months ago - Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical - Seeking Alpha
- 8 months ago - Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - GlobeNewsWire